AIDS

Recent progress in anti-HIV broadly neutralizing antibody research
pp. N21-N21(1)
Author: Tobin, Stacey C.

Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries
pp. 2179-2191(13)
Authors: Hoornenborg, Elske; Krakower, Douglas S.; Prins, Maria; Mayer, Kenneth H.

Delivering preexposure prophylaxis to pregnant and breastfeeding women in Sub-Saharan Africa: the implementation science frontier
pp. 2193-2197(5)
Authors: Joseph Davey, Dvora L.; Bekker, Linda-Gail; Gorbach, Pamina M.; Coates, Thomas J.; Myer, Landon

Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses
pp. 2199-2209(11)
Authors: Scheepers, Cathrine; Chowdhury, Sudipa; Wright, W. Shea; Campbell, Christopher T.; Garrett, Nigel J.; Abdool Karim, Quarraisha; Abdool Karim, Salim S.; Moore, Penny L.; Gildersleeve, Jeffrey C.; Morris, Lynn

Preferential susceptibility of Th9 and Th2 CD4⁺ T cells to X4-tropic HIV-1 infection
pp. 2211-2215(5)
Authors: Orlova-Fink, Nina; Chowdhury, Fatema Z.; Sun, Xiaoming; Harrington, Sean; Rosenberg, Eric S.; Yu, Xu G.; Lichterfeld, Mathias

Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults
pp. 2217-2225(9)
Authors: Bisson, Gregory P.; Ramchandani, Ritesh; Miyahara, Sachiko; Mngqibisa, Rosie; Matoga, Mitch; Ngongondo, McNeil; Samaneka, Wadzanai; Koech, Lucy; Naidoo, Kogieleum; Rassool, Mohammed; Kirui, Fredrick; Banda, Peter; Mave, Vidya; Kadam, Dileep; Leger, Paul; Henestroza, German; Manabe, Yukari C.; Bao, Jing; Kumwenda, Johnstone; Gupta, Amita; Hosseinipour, Mina C.

The role of oncogenic human papillomavirus determination for diagnosis of high-grade anal intraepithelial neoplasia in HIV-infected MSM
pp. 2227-2233(7)
Authors: Burgos, Joaquin; Hernández-Losa, Javier; Landolfi, Stefania; Guelar, Ana; Dinares, MªCarmen; Villar, Judith; Navarro, Jordi; Ribera, Esteve; Falcó, Vicenç; Curran, Adria

Pretreatment integrase strand transfer inhibitor resistance in North Carolina from 2010–2016
pp. 2235-2244(10)
Authors: Menza, Timothy W.; Billock, Rachael; Samoff, Erika; Eron, Joseph J.; Dennis, Ann M.

Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen
pp. 2245-2251(7)
Authors: Gandhi, Monica; Murnane, Pamela M.; Bacchetti, Peter; Elion, Richard; Kolber, Michael A.; Cohen, Stephanie E.; Horng, Howard; Louie, Alexander; Kuncze, Karen; Koss, Catherine A.; Anderson, Peter L.; Buchbinder, Susan; Liu, Albert

Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV
pp. 2253-2259(7)
Authors: Fourman, Lindsay T.; Czerwonka, Natalia; Feldpausch, Meghan N.; Weiss, Julian; Mamputu, Jean-Claude; Falutz, Julian; Morin, Josée; Marsolais, Christian; Stanley, Takara L.; Grinspoon, Steven K.

Reproductive coercion among women living with HIV: an unexplored risk factor for negative sexual and mental health outcomes
pp. 2261-2265(5)
Authors: Anderson, Jocelyn C.; Grace, Karen Trister; Miller, Elizabeth

Antiretroviral combination use during pregnancy and the risk of major congenital malformations
pp. 2267-2277(11)
Authors: Bérard, Anick; Sheehy, Odile; Zhao, Jin-Ping; Abrahamowicz, Michal; Loutfy, Mona; Boucoiran, Isabelle; Bernatsky, Sasha

The costs of HIV treatment and care in Ghana
pp. 2279-2286(8)
Authors: Mikkelsen, Evelinn; Hontelez, Jan A.C.; Nonvignon, Justice; Amon, Sam; Asante, Felix A.; Aikins, Moses K.; van de Haterd, Julie; Baltussen, Rob

Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults
pp. 2287-2294(8)
Authors: Tassiopoulos, Katherine; Abdo, Mona; Wu, Kunling; Koletar, Susan L.; Palella, Frank J.; Kalayjian, Robert; Taiwo, Babafemi; Erlandson, Kristine M.

Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: is targeted screening possible?
pp. 2295-2301(7)
Authors: Siegenbeek van Heukelom, Matthijs L.; Marra, Elske; de Vries, Henry J.C.; van der Loeff, Maarten F. Schim; Prins, Jan M.

Were we prepared for PrEP? Five years of implementation
pp. 2303-2305(3)
Authors: Weinstein, Michael; Yang, Otto O.; Cohen, Adam C.

The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro
pp. 2307-2309(3)
Authors: Saladini, Francesco; Giannini, Alessia; Boccuto, Adele; Tiezzi, Diletta; Vicenti, Ilaria; Zazzi, Maurizio

Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma
pp. 2311-2313(3)
Authors: Vase, Maja Ølholm; Ludvigsen, Maja; Bendix, Knud; Dutoit, Stephen H.; Hjortebjerg, Rikke; Petruskevicius, Irma; Møller, Michael B.; Pedersen, Gitte; Denton, Paul W.; Honoré, Bent; Rabinovich, Gabriel A.; Larsen, Carsten S.; d’Amore, Francesco

Successful treatment with tenofovir alafenamide of a HIV/hepatitis B virus coinfected patient with HIV and hepatitis B virus drug resistance, end-stage renal disease on haemodialysis
pp. 2314-2315(2)
Authors: Tartaglia, Alessandra; Ferrara, Sergio Maria; Sica, Salvatore; Santantonio, Teresa